These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23994801)

  • 21. Bone marrow transplantation from an HLA-matched unrelated donor for treatment of Chediak-Higashi syndrome.
    Liang JS; Lu MY; Tsai MJ; Lin DT; Lin KH
    J Formos Med Assoc; 2000 Jun; 99(6):499-502. PubMed ID: 10925557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chédiak-Higashi syndrome: presentation of seven cases.
    Carnide EM; Jacob CM; Pastorino AC; Bellinati-Pires R; Costa MB; Grumach AS
    Sao Paulo Med J; 1998; 116(6):1873-8. PubMed ID: 10349196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Living-Donor Lung Transplantation After Bone Marrow Transplantation for Chediak-Higashi Syndrome.
    Yamada T; Chen-Yoshikawa TF; Oh S; Ito-Taniguchi R; Gochi F; Sato M; Aoyama A; Date H
    Ann Thorac Surg; 2017 Mar; 103(3):e281-e283. PubMed ID: 28219570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anesthesia in Che'diak-Higashi syndrome--case report.
    Ulsoy H; Erciyes N; Ovali E; Kalac N; Ulusoy S; Albayrak D
    Middle East J Anaesthesiol; 1995 Feb; 13(1):101-5. PubMed ID: 7565417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chediak-Higashi syndrome: report of a case with uncommon presentation and review literature.
    Kanjanapongkul S
    J Med Assoc Thai; 2006 Apr; 89(4):541-4. PubMed ID: 16696403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammatory demyelinating neuropathy heralding accelerated chediak-higashi syndrome.
    Faber IV; Prota JRM; Martinez ARM; Nucci A; Lopes-Cendes I; Júnior MCF
    Muscle Nerve; 2017 May; 55(5):756-760. PubMed ID: 27669550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chediak-Higashi syndrome: neurocognitive and behavioral data from infancy to adulthood after bone marrow transplantation.
    Yliranta A; Mäkinen J
    Neurocase; 2021 Feb; 27(1):1-7. PubMed ID: 33295840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome.
    Jessen B; Maul-Pavicic A; Ufheil H; Vraetz T; Enders A; Lehmberg K; Längler A; Gross-Wieltsch U; Bay A; Kaya Z; Bryceson YT; Koscielniak E; Badawy S; Davies G; Hufnagel M; Schmitt-Graeff A; Aichele P; Zur Stadt U; Schwarz K; Ehl S
    Blood; 2011 Oct; 118(17):4620-9. PubMed ID: 21878672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of the skin biopsy as a tool in the diagnosis of silvery hair syndrome.
    Ridaura-Sanz C; Durán-McKinster C; Ruiz-Maldonado R
    Pediatr Dermatol; 2018 Nov; 35(6):780-783. PubMed ID: 30338556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus infection in Chediak-Higashi syndrome mimicking acute lymphocytic leukemia.
    Kinugawa N
    Am J Pediatr Hematol Oncol; 1990; 12(2):182-6. PubMed ID: 2165746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motor neuronopathy in Chediak-Higashi syndrome.
    Mathis S; Cintas P; de Saint-Basile G; Magy L; Funalot B; Vallat JM
    J Neurol Sci; 2014 Sep; 344(1-2):203-7. PubMed ID: 25043664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chediak-higashi syndrome presented as accelerated phase: case report and review of the literature.
    Bouatay A; Hizem S; Tej A; Moatamri W; Boughamoura L; Kortas M
    Indian J Hematol Blood Transfus; 2014 Sep; 30(Suppl 1):223-6. PubMed ID: 25332584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral mass revealing Chédiak-Higashi syndrome.
    Tsuji T; Uemura Y; Nakamura Y; Nonoyama S
    Int J Oral Maxillofac Surg; 2017 Sep; 46(9):1158-1161. PubMed ID: 28456452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chediak-Higashi syndrome].
    Wolf J; Jacobi C; Breer H; Grau A
    Nervenarzt; 2006 Feb; 77(2):148, 150-2, 155-7. PubMed ID: 16205875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accelerated phase of chediak higashi syndrome mimicking lymphoma--a case report.
    Nargund AR; Madhumathi DS; Premalatha CS; Rao CR; Appaji L; Lakshmidevi V
    J Pediatr Hematol Oncol; 2010 Aug; 32(6):e223-6. PubMed ID: 20661157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards the targeted management of Chediak-Higashi syndrome.
    Lozano ML; Rivera J; Sánchez-Guiu I; Vicente V
    Orphanet J Rare Dis; 2014 Aug; 9():132. PubMed ID: 25129365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic bone marrow transplantation in Chédiak-Higashi syndrome.
    Möttönen M; Lanning M; Saarinen UM
    Pediatr Hematol Oncol; 1995; 12(1):55-9. PubMed ID: 7703042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
    Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
    J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak-Higashi syndromes by HLH directed therapy.
    Trottestam H; Beutel K; Meeths M; Carlsen N; Heilmann C; Pasić S; Webb D; Hasle H; Henter JI
    Pediatr Blood Cancer; 2009 Feb; 52(2):268-72. PubMed ID: 18937330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Secretory lysosome disorders in the immune synapse and other tissues].
    García IJ; Miñarro AG; Riestra EL; Cortés MB; Miguélez SA; Soler JL
    An Pediatr (Barc); 2012 Feb; 76(2):92-7. PubMed ID: 22032885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.